{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:06:53Z","timestamp":1790492813169,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Capital Development of Medical Scientific Research Funds","award":["2009-3026"],"award-info":[{"award-number":["2009-3026"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.peptides.2019.170200","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T02:31:43Z","timestamp":1573525903000},"page":"170200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Catestatin in defense of oxidative-stress-induced apoptosis: A novel mechanism by activating the beta2 adrenergic receptor and PKB\/Akt pathway in ischemic-reperfused myocardium"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-4054","authenticated-orcid":false,"given":"Song-Yun","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ning","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2019.170200_bib0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCRESAHA.114.300559","article-title":"Cardiac mitochondria and reactive oxygen species generation","volume":"114","author":"Chen","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coph.2016.01.006","article-title":"Mitochondrial redox status as a target for cardiovascular disease","volume":"27","author":"Walters","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.peptides.2019.170200_bib0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","article-title":"Reperfusion injury and reactive oxygen species: the evolution of a concept","volume":"6","author":"Granger","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.peptides.2019.170200_bib0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0008-6363(03)00344-4","article-title":"Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion","volume":"59","author":"Zhao","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/ars.2007.9.49","article-title":"Mechanisms of cell death in oxidative stress","volume":"9","author":"Ryter","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.peptides.2019.170200_bib0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","article-title":"Reactive oxygen species, cellular redox systems, and apoptosis","volume":"48","author":"Circu","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.peptides.2019.170200_bib0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1203\/00006450-199607000-00011","article-title":"Metabolic compartmentalization in neonatal swine myocytes","volume":"40","author":"Livingston","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0040","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1172\/JCI119686","article-title":"Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist","volume":"100","author":"Mahata","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2019.170200_bib0045","doi-asserted-by":"crossref","first-page":"32058","DOI":"10.1074\/jbc.M305545200","article-title":"Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter\/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin","volume":"278","author":"Mahata","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.170200_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.regpep.2010.01.006","article-title":"Catestatin: a multifunctional peptide from chromogranin A","volume":"162","author":"Mahata","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2019.170200_bib0055","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1172\/JCI24354","article-title":"Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog","volume":"115","author":"Mahapatra","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2019.170200_bib0060","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1161\/HYPERTENSIONAHA.112.202127","article-title":"Novel peptide isomer strategy for stable inhibition of catecholamine release: application to hypertension","volume":"60","author":"Biswas","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2019.170200_bib0065","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/en.2008-0318","article-title":"The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine\/paracrine modulator of cardiac inotropism and lusitropism","volume":"149","author":"Angelone","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2019.170200_bib0070","doi-asserted-by":"crossref","first-page":"H113","DOI":"10.1152\/ajpheart.00172.2008","article-title":"Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart","volume":"295","author":"Mazza","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.peptides.2019.170200_bib0075","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1242\/jeb.045567","article-title":"The catecholamine release-inhibitory peptide catestatin (chromogranin A344-363) modulates myocardial function in fish","volume":"213","author":"Imbrogno","year":"2010","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.peptides.2019.170200_bib0080","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2174\/0929867324666170425100416","article-title":"Catestatin: a master regulator of cardiovascular functions","volume":"25","author":"Mahata","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.peptides.2019.170200_bib0085","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1210\/en.2009-0429","article-title":"Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse","volume":"150","author":"Gayen","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2019.170200_bib0090","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/en.2009-1110","article-title":"Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment","volume":"151","author":"Dev","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2019.170200_bib0095","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.110.219493","article-title":"The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism","volume":"107","author":"Theurl","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2012-05-430314","article-title":"A new chromogranin A-dependent angiogenic switch activated by thrombin","volume":"121","author":"Crippa","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.peptides.2019.170200_bib0105","doi-asserted-by":"crossref","first-page":"23141","DOI":"10.1074\/jbc.M111.335877","article-title":"Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling","volume":"287","author":"Bandyopadhyay","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.170200_bib0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1160\/TH17-05-0349","article-title":"Catestatin prevents macrophage-driven atherosclerosis but not arterial injury-induced neointimal hyperplasia","volume":"118","author":"Kojima","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.peptides.2019.170200_bib0115","article-title":"Catestatin regulates epithelial cell dynamics to improve intestinal inflammation","volume":"6","author":"Eissa","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.peptides.2019.170200_bib0120","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3389\/fimmu.2018.02199","article-title":"Catestatin as a target for treatment of inflammatory diseases","volume":"9","author":"Muntjewerff","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.peptides.2019.170200_bib0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2018.12.025","article-title":"Decreased circulating catestatin levels are associated with coronary artery disease: the emerging anti-inflammatory role","volume":"281","author":"Chen","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.peptides.2019.170200_bib0130","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.14249","article-title":"Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation","author":"Mahata","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.peptides.2019.170200_bib0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/psc.2634","article-title":"Antioxidant properties of a human neuropeptide and its protective effect on free radical-induced DNA damage","volume":"20","author":"Mohseni","year":"2014","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.peptides.2019.170200_bib0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/postgradmedj-2012-131060","article-title":"Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling","volume":"89","author":"Meng","year":"2013","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.peptides.2019.170200_bib0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.peptides.2013.05.003","article-title":"Plasma levels and diagnostic value of catestatin in patients with heart failure","volume":"46","author":"Liu","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2019.170200_bib0150","doi-asserted-by":"crossref","first-page":"16590","DOI":"10.1038\/srep16590","article-title":"Catestatin attenuates endoplasmic reticulum induced cell apoptosis by activation type 2 muscarinic acetylcholine receptor in cardiac ischemia\/reperfusion","volume":"5","author":"Liao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2019.170200_bib0155","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00424-013-1217-0","article-title":"Catestatin reduces myocardial ischaemia\/reperfusion injury: involvement of PI3K\/Akt, PKCs, mitochondrial KATP channels and ROS signalling","volume":"465","author":"Perrelli","year":"2013","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.peptides.2019.170200_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119790","article-title":"Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia\/reperfusion by stimulating PI3K-Akt-GSK3beta pathway and preserving mitochondrial membrane potential","volume":"10","author":"Bassino","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170200_bib0165","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.yjmcc.2011.06.012","article-title":"Methods in cardiomyocyte isolation, culture, and gene transfer","volume":"51","author":"Louch","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.peptides.2019.170200_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102536","article-title":"Catestatin increases the expression of anti-apoptotic and pro-angiogenetic factors in the post-ischemic hypertrophied heart of SHR","volume":"9","author":"Penna","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170200_bib0175","doi-asserted-by":"crossref","first-page":"22905","DOI":"10.1074\/jbc.M001232200","article-title":"Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules","volume":"275","author":"Taylor","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.170200_bib0180","first-page":"1525","article-title":"Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity","volume":"14","author":"Mahata","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.peptides.2019.170200_bib0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00441-010-1059-4","article-title":"Chromogranin\/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364-384))","volume":"342","author":"Biswas","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0190","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/1354750X.2011.629058","article-title":"Catestatin is useful in detecting patients with stage B heart failure","volume":"16","author":"Zhu","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.peptides.2019.170200_bib0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/1354750X.2011.578260","article-title":"Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction","volume":"16","author":"Wang","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.peptides.2019.170200_bib0200","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10571-010-9598-5","article-title":"Catestatin improves post-ischemic left ventricular function and decreases ischemia\/reperfusion injury in heart","volume":"30","author":"Penna","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.peptides.2019.170200_bib0205","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.2174\/092986712802429966","article-title":"Cardioprotection against ischemia\/reperfusion injury and chromogranin A-derived peptides","volume":"19","author":"Penna","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.peptides.2019.170200_bib0210","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cvr\/cvr129","article-title":"A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K-eNOS pathway in the myocardium","volume":"91","author":"Bassino","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0215","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cardiores.2003.12.023","article-title":"Role of apoptosis in reperfusion injury","volume":"61","author":"Eefting","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0220","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.RES.86.3.264","article-title":"Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury","volume":"86","author":"Yoshida","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0225","first-page":"216","article-title":"Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury","author":"Yoshida","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2019.170200_bib0230","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1073\/pnas.95.8.4556","article-title":"Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury","volume":"95","author":"Wang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2019.170200_bib0235","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.freeradbiomed.2008.06.021","article-title":"Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia\/reperfusion-associated cardiac dysfunction","volume":"45","author":"Dabkowski","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.peptides.2019.170200_bib0240","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.peptides.2019.170200_bib0245","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2202-14-118","article-title":"The effects of different doses of estradiol (E2) on cerebral ischemia in an in vitro model of oxygen and glucose deprivation and reperfusion and in a rat model of middle carotid artery occlusion","volume":"14","author":"Ma","year":"2013","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.peptides.2019.170200_bib0250","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/1521-2254(200009\/10)2:5<326::AID-JGM133>3.0.CO;2-1","article-title":"Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia\/reperfusion injury","volume":"2","author":"Brocheriou","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/j.peptides.2019.170200_bib0255","doi-asserted-by":"crossref","first-page":"H2313","DOI":"10.1152\/ajpheart.2001.280.5.H2313","article-title":"Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I\/R injury in transgenic mice","volume":"280","author":"Chen","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.peptides.2019.170200_bib0260","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.111.259952","article-title":"AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes","volume":"110","author":"Oliveira","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0265","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1172\/JCI19297","article-title":"AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury","volume":"114","author":"Russell","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2019.170200_bib0270","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.apsb.2016.12.003","article-title":"Dissecting the role of AMP-activated protein kinase in human diseases","volume":"7","author":"Li","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.peptides.2019.170200_bib0275","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1089\/ars.2010.3360","article-title":"Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin","volume":"14","author":"Hausenloy","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.peptides.2019.170200_bib0280","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","article-title":"New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway","volume":"61","author":"Hausenloy","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0285","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","article-title":"Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery","volume":"91","author":"Datta","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2019.170200_bib0290","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.282.5392.1318","article-title":"Regulation of cell death protease caspase-9 by phosphorylation","volume":"282","author":"Cardone","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.peptides.2019.170200_bib0295","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/01.CIR.0000130647.29030.90","article-title":"Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning","volume":"109","author":"Uchiyama","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2019.170200_bib0300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10741-007-9026-1","article-title":"Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection","volume":"12","author":"Hausenloy","year":"2007","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.peptides.2019.170200_bib0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(00)00135-X","article-title":"Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism","volume":"95","author":"Taupenot","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.peptides.2019.170200_bib0310","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s10753-012-9449-2","article-title":"Postconditioning with alpha7nAChR agonist attenuates systemic inflammatory response to myocardial ischemia--reperfusion injury in rats","volume":"35","author":"Xiong","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.peptides.2019.170200_bib0315","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.yjmcc.2011.06.019","article-title":"beta2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways","volume":"51","author":"Fajardo","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.peptides.2019.170200_bib0320","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/01.RES.87.12.1172","article-title":"The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3\u2032-kinase","volume":"87","author":"Chesley","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0325","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.98.4.1607","article-title":"Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes","volume":"98","author":"Zhu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2019.170200_bib0330","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.7150\/thno.26619","article-title":"Pepducin-mediated cardioprotection via beta-arrestin-biased beta2-adrenergic receptor-specific signaling","volume":"8","author":"Grisanti","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.peptides.2019.170200_bib0335","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/ATVBAHA.112.251769","article-title":"Selective beta2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury","volume":"32","author":"Bhushan","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.peptides.2019.170200_bib0340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.phrs.2015.12.032","article-title":"Higenamine protects ischemia\/reperfusion induced cardiac injury and myocyte apoptosis through activation of beta2-AR\/PI3K\/AKT signaling pathway","volume":"104","author":"Wu","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.peptides.2019.170200_bib0345","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/01.RES.0000184615.56822.bd","article-title":"The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly","volume":"97","author":"Zhu","year":"2005","journal-title":"Circ. Res."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:47:54Z","timestamp":1762264074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119301780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":69,"alternative-id":["S0196978119301780"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170200","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catestatin in defense of oxidative-stress-induced apoptosis: A novel mechanism by activating the beta2 adrenergic receptor and PKB\/Akt pathway in ischemic-reperfused myocardium","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"170200"}}